Related Experiment Video

Updated: May 2, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.6K

Inhibition of hepatitis B virus cccDNA by siRNA in transgenic mice

Guiqiu Li1, Guotao Jiang, Juan Lu

  • 1Department of Clinical Laboratory, The Affiliated First Hospital of Harbin Medical University, Harbin, 150001, China.

Cell Biochemistry and Biophysics
|February 27, 2014
PubMed

Insights

Small interfering RNA (siRNA) therapy shows promise for treating chronic hepatitis B virus (HBV) infection. siRNA effectively suppressed HBV replication and inhibited viral covalently closed circular DNA (cccDNA) amplification in a mouse model.

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology

Background:

  • Chronic hepatitis B virus (HBV) infection is difficult to clear due to the persistence of viral covalently closed circular DNA (cccDNA) in hepatocytes.
  • Sustained viral clearance remains a challenge in current antiviral therapy for HBV.

Purpose of the Study:

  • To evaluate the efficacy of small interfering RNA (siRNA) in suppressing HBV replication and cccDNA amplification.
  • To assess siRNA as a potential therapeutic agent against HBV infection using a transgenic mouse model.

Main Methods:

  • Utilized an HBV-transgenic mouse model to study the effects of siRNA treatment.
  • Monitored viral replication, antigen expression, and cccDNA amplification levels.

Main Results:

  • siRNA demonstrated a significant inhibitory effect on HBV replication and antigen expression in the studied mice.
  • A marked inhibition of HBV cccDNA amplification was observed following siRNA treatment.
  • siRNA emerged as an efficient agent against HBV, outperforming other antiviral approaches.

Conclusions:

  • siRNA therapy is a potent strategy for inhibiting HBV replication and cccDNA amplification.
  • siRNA represents a promising alternative therapeutic approach for chronic hepatitis B infection.
  • Targeting viral cccDNA with siRNA offers a potential pathway to sustained viral clearance.

More Related Videos

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

12.9K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.2K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58